Oxidative stress, antioxidants, and assessment of oxidative stress in dogs and cats

Journal of the American Veterinary Medical Association

Volumn 231, Issue 5, 2007, Pages 714-720

  McMichael, Maureen A ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VITAMIN;

ANIMAL; ANIMAL FOOD; CAT; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; DOG; DRUG EFFECT; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; ANTIOXIDANTS; CATS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DOGS; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMINS;

ANIMALIA; CANIS FAMILIARIS;

EID: 34548401564     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.231.5.714     Document Type: Review

References (77)

1. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 2007;115:81-103.
2. Korantzopoulos P, Kolettis TM, Galaris D, et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115:135-143.
3. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 2006;21:438-449.
4. Montuschi P, Barnes P, Roberts LJ. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703-717.
5. Hermans N, Cos P, Maes L, et al. Challenges and pitfalls in antioxidant research. Curr Med Chem 2007;14:417-430.
6. Bulteau AL, Szweda LI, Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp Gerontol 2006;41:653-657.
7. Rangan U, Bulkley GB. Prospects for treatment of free radical-mediated tissue injury. Br Med Bull 1993;49:700-718.
8. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002;265:49-72.
9. Wei YH. Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med 1998;217:53-63.
10. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-487.
11. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 1999;31:261-272.
12. Opara EC. Oxidative stress. Dis Mon 2006;52:183-198.
13. Eaton S. The biochemical basis of antioxidant therapy in critical illness. Proc Nutr Soc 2006;65:242-249.
14. Miller NJ, Rice-Evans C, Davies MJ, et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993;84:407-412.
15. Soejima A, Matsuzawa N, Hayashi T, et al. Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif 2004;22:525-529.
16. Bar-Or D, Bar-Or R, Rael LT, et al. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005;33:1638-1641.
17. Meydani M. Vitamin E. Lancet 1995;345:170-175.
18. Sciuto AM. Antioxidant properties of glutathione and its role in tissue protection. In: Baskin S, Salem H, eds. Oxidants, antioxidants, and free radicals. Washington, DC: Taylor & Francis, 1997;171-191.
19. Kurose I, Higuchi H, Miura S, et al. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 1997;25:368-378.
20. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 2000;28:1745-1750.
21. Moore K, Roberts LJ. Measurement of lipid peroxidation. Free Radic Res 1998;28:659-671.
22. McMillan RM, MacIntyre DE, Booth A, et al. Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase. Biochem J 1978;176:595-598.
23. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
24. Morrow JD, Roberts LJ. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002;166:S25-S30.
25. Roberts LJ, Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta 1997;1345:121-135.
26. Reilly M, Delanty N, Lawson JA, et al. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996;94:19-25.
27. 2t isoprostane in urine of dogs with intervertebral disk disease. Am J Vet Res 2006;67:1226-1231.
28. Brisson BA, Miller CW, Chen G, et al. Effects of adenosine pre-treatment on detection of free radicals in ischemic and reperfused canine gracilis muscle flaps by use of spin-trapping electron paramagnetic resonance spectroscopy. Am J Vet Res 2002;63:175-180.
29. Brisson BA, Miller CW, Chen G, et al. Detection of free radicals in ischemic and reperfused canine gracilis muscle flaps by use of spin-trapping electron paramagnetic resonance spectroscopy. Am J Vet Res 2001;62:384-388.
30. Cutler RG. Oxidative stress profiling: part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 2005;1055:93-135.
31. Cutler RG, Plummer J, Chowdhury K, et al. Oxidative stress profiling: part II. Theory, technology, and practice. Ann N Y Acad Sci 2005;1055:136-158.
32. Center SA, Warner KL, Erb HN. Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 2002;63:1187-1197.
33. Reiter R, Wendel A. Chemically-induced glutathione depletion and lipid peroxidation. Chem Biol Interact 1982;40:365-374.
34. Hinchcliff KW, Reinhart GA, DiSilvestro R, et al. Oxidant stress in sled dogs subjected to repetitive endurance exercise. Am J Vet Res 2000;61:512-517.
35. Baskin CR, Hinchcliff KW, DiSilvestro RA, et al. Effects of dietary antioxidant supplementation on oxidative damage and resistance to oxidative damage during prolonged exercise in sled dogs. Am J Vet Res 2000;61:886-891.
36. Szabo G, Bahrle S, Fazekas L, et al. Endothelin-A receptor antagonist BQ123 protects against myocardial and endothelial reperfusion injury. Thorac Cardiovasc Surg 1998;46:232-236.
37. Harada K, Sugaya T, Murakami K, et al. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 1999;100:2093-2099.
38. Buras JA, Stahl GL, Svoboda KK, et al. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol 2000;278:C292-C302.
39. Marino P. The threat of oxidant injury. In: Marino P, ed. The ICU book. Baltimore: The Williams & Wilkins Co, 1998;32-50.
40. Scott BC, Aruoma OI, Evans PJ, et al. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res 1994;20:119-133.
41. Bernard GR, Lucht WD, Niedermeyer ME, et al. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984;73:1772-1784.
42. Revesz L, Malaise E. Significance of cellular glutathione in radioprotection and repair of radiation damage. In: Larsson A, ed. Function of glutathione: biochemical, physiological, toxicological, and clinical aspects. New York: Raven Press, 1983;163-173.
43. Sciuto AM, Strickland PT, Kennedy TP, et al. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Respir Crit Care Med 1995;151:768-772.
44. Carroll JE, Howard EF, Hess DC, et al. Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol Brain Res 1998;56:186-191.
45. Ferrari R, Ceconi C, Curello S, et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 1991;91:95S-105S.
46. Henderson A, Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: potential new use for an old drug. Ann Pharmacother 1994;28:1086-1088.
47. Suter PM, Domenighetti G, Schaller MD, et al. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994;105:190-194.
48. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-2782.
49. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-1347.
50. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.
51. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
52. Sander S, Coleman CI, Patel AA, et al. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 2006;12:464-472.
53. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 1997;18(suppl):S159-S168.
54. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 1999;6:167-178.
55. Toledo-Pereyra LH, Simmons RL, Najarian JS. Effect of allopurinol on the preservation of ischemic kidneys perfused with plasma or plasma substitutes. Ann Surg 1974;180:780-782.
56. O'Farrell D, Chen LE, Seaber AV, et al. Efficacy of recombinant human manganese superoxide dismutase compared to allopurinol in protection of ischemic skeletal muscle against "no-reflow". J Reconstr Microsurg 1995;11:207-214.
57. Negita M, Ishii T, Kunikata S, et al. Prevention of posttransplant acute tubular necrosis in kidney graft by perioperative superoxide dismutase infusion. Transplant Proc 1994;26:2123-2124.
58. Zimmerman BJ, Grisham MB, Granger DN. Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 1990;258:G185-G190.
59. Jolly SR, Kane WJ, Bailie MB, et al. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984;54:277-285.
60. Galey JB. Recent advances in the design of iron chelators against oxidative damage. Mini Rev Med Chem 2001;1:233-242.
61. Menasche P, Antebi H, Alcindor LG, et al. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation 1990;82:IV390-IV396.
62. Haraldsson G, Sorensen V, Nilsson U, et al. Effect of pre-treatment with desferrioxamine and mannitol on radical production and kidney function after ischaemia-reperfusion. A study on rabbit kidneys. Acta Physiol Scand 1995;154:461-468.
63. deLemos RA, Roberts RJ, Coalson JJ, et al. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. Am J Dis Child 1990;144:915-919.
64. Zimmerman BJ, Guillory DJ, Grisham MB, et al. Role of leukotriene B4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology 1990;99:1358-1363.
65. Sekizuka E, Benoit JN, Grisham MB, et al. Dimethylsulfoxide prevents chemoattractant-induced leukocyte adherence. Am J Physiol 1989;256:H594-H597.
66. Schiller HJ, Reilly PM, Bulkley GB. Tissue perfusion in critical illnesses. Antioxidant therapy. Crit Care Med 1993;21:S92-S102.
67. Engler MB, Engler MM. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 2006;64:109-118.
68. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 2006;41:1727-1746.
69. Steffen Y, Schewe T, Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun 2005;331:1277-1283.
70. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-342.
71. Roudebush P, Zicker SC, Cotman CW, et al. Nutritional management of brain aging in dogs. J Am Vet Med Assoc 2005;227:722-728.
72. Mutoh M, Takahashi M, Fukuda K, et al. Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn J Cancer Res 2000;91:686-691.
73. Denosyl SD4 [package insert]. Edgewood, Md: Nutramax Laboratories Inc, 2006.
74. Cakir O, Kamalettin E, Oruc A, et al. Neuroprotective effect of N-acetylcysteine and hypothermia on spinal cord ischemia-reperfusion injury. Cardiovasc Surg 2003;11:375-379.
75. Williams D. Exocrine pancreatic disease. In: Ettinger S, Feldman E, eds. Textbook of veterinary internal medicine. 6th ed. Philadelphia: WB Saunders Co, 2005; 135-167.
76. Plumb D. Ascorbic acid/Vitamin C. In: Plumb D, ed. Veterinary drug handbook. 4th ed. Ames, Iowa: Iowa State University Press, 2002;69.
77. Langsjoen PH, Langsjoen A, Willis R, et al. Treatment of hypertrophic cardiomyopathy with coenzyme Q10. Molec Aspects Med 1997;suppl 18.S145-S151.